The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery

Abstract

PolyHeme is safe in acute blood loss, maintains total [Hb] in lieu of red cells despite the marked fall in RBC [Hb], and reduces the use of allogeneic blood. PolyHeme appears to be a clinically useful blood substitute.